Novogene(SH:688315) Xin Lang Cai Jing·2025-10-23 09:20Core Viewpoint - The company announced a meeting on October 23, 2025, to review and approve the proposal for asset impairment provision, reflecting a cautious approach to asset evaluation as of September 30, 2025 [1] Financial Impact - The total amount of impairment provision recognized is approximately 24.53 million yuan, which includes credit impairment losses of 24.36 million yuan and asset impairment losses of 0.17 million yuan [1] - This impairment provision will reduce the company's pre-tax profit by 24.53 million yuan for the first three quarters of 2025, consequently decreasing the owner's equity at the end of the reporting period [1] - The data presented is unaudited and will be confirmed by annual audit [1] Governance - Both the board of directors and the audit committee have agreed to this impairment provision [1]